Medtech Industry’s Wishlist For MHRA’s New UK Regulatory Structure
Convergence with EU regulation, enhanced patient safety and speedy delivery of innovation preoccupy UK medtechs going into 2022
Executive Summary
The UK's medtech regulatory consultation has closed and the MHRA must now assess the views of stakeholders on the 465 questions designed to help shape the foundations of a future-proofed regulatory system. But time is tight, as speakers at the ABHI’s annual regulatory conference were at pains to stress.